Caprolactone

Mike Smith elects to retire as executive vice president and president, performance chemicals, strategy and business development of Ingevity

Retrieved on: 
Thursday, December 9, 2021
Chemicals, Plastics, Manufacturing, FMC Corporation, University, NYSE, Caprolactone, Forward-looking statement, SEC, Manchester Metropolitan University, Growth, White, Adhesive, Leadership, Polymer, Private Securities Litigation Reform Act, Lubricant, Agrochemical, Gasoline, Evonik Industries, Business administration, Securities Exchange Act of 1934, Air Products & Chemicals, Corporation, Elastomer, COVID-19, Chemistry, Marketing, Sale, New, Annual report, Morgan State University, Master of Business Administration, DuPont, Risk, Management

Ingevity Corporation (NYSE:NGVT) today announced that effective March 1, 2022, Mike Smith has elected to retire as executive vice president and president, Performance Chemicals, strategy and business development.

Key Points: 
  • Ingevity Corporation (NYSE:NGVT) today announced that effective March 1, 2022, Mike Smith has elected to retire as executive vice president and president, Performance Chemicals, strategy and business development.
  • Beginning January 1, 2022, Rich White, vice president, Industrial Specialties, and Steve Hulme, vice president, Engineered Polymers, at Ingevity will co-lead the companys Performance Chemicals segment.
  • At that time, White will become senior vice president, Performance Chemicals, and president, Industrial Specialties and Pavement Technologies, and Hulme will be senior vice president, Performance Chemicals, and president, Engineered Polymers.
  • White joined Ingevity in 2019 from DuPont Nutrition and Health in Copenhagen, Denmark, where he was vice president of global accounts.

Ingevity increases caprolactone monomer capacity at its Warrington, UK facility

Retrieved on: 
Wednesday, October 13, 2021
Packaging, Engineering, Chemicals, Plastics, Automotive Manufacturing, Manufacturing, Other Manufacturing, Securities Exchange Act of 1934, Private Securities Litigation Reform Act, New, Solution, Gasoline, Growth, Adhesive, Corporation, SEC, NYSE, Agrochemical, Caprolactone, Lubricant, Elastomer, News, Forward-looking statement, Annual report, CAPA, Risk, Polymer, Smith, COVID-19, Renewable energy

Ingevity Corporation (NYSE:NGVT) today announced that it will increase caprolactone monomer capacity at its facility in Warrington, U.K., through a series of optimization projects over the next 12 months that are expected to increase Ingevitys global monomer production capacity by over 20% and position the company to better meet demand and more effectively serve customers.

Key Points: 
  • Ingevity Corporation (NYSE:NGVT) today announced that it will increase caprolactone monomer capacity at its facility in Warrington, U.K., through a series of optimization projects over the next 12 months that are expected to increase Ingevitys global monomer production capacity by over 20% and position the company to better meet demand and more effectively serve customers.
  • Ingevity provides products and technologies that purify, protect and enhance the world around us.
  • Headquartered in North Charleston, South Carolina, Ingevity operates from 25 locations around the world and employs approximately 1,850 people.
  • Ingevity assumes no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this press release.

Ingevity to add caprolactone polyol production in DeRidder, Louisiana

Retrieved on: 
Thursday, February 18, 2021
Chemicals, Plastics, Manufacturing, Organic compounds, Polymers, Chemistry, Polyol, Polycaprolactone, Caprolactone, Adhesive, CAPA

Ingevity Corporation (NYSE: NGVT) today announced that it will add caprolactone polyol production capabilities at its facility in DeRidder, Louisiana.

Key Points: 
  • Ingevity Corporation (NYSE: NGVT) today announced that it will add caprolactone polyol production capabilities at its facility in DeRidder, Louisiana.
  • Global demand for its Capa suite of caprolactone technologies primarily for industrial equipment, adhesives, coatings, and automotive applications is increasing.
  • The DeRidder upgrades will increase Ingevitys global polyol production capacity by 40%, positioning the company to better meet demand and more effectively serve its customers.
  • Ingevity also operates a polycaprolactone production facility in Warrington, U.K.
    Ingevity provides products and technologies that purify, protect, and enhance the world around us.

Ingevity completes acquisition of Capa™ caprolactone division of Perstorp Holding AB

Retrieved on: 
Wednesday, February 13, 2019
Energy, Other Energy, Technology, Other Technology, Manufacturing, Chemicals, Plastics, Engineering, Packaging, Other Manufacturing, Natural Resources, Mining, Minerals, Other Natural Resources, Caprolactone, Lactones, Monomers, CAPA, Columbus Association for the Performing Arts

Ingevity Corporation (NYSE: NGVT) has completed its acquisition of the Capa caprolactone division of Perstorp Holding AB for a cash purchase price of 578.9 million ($652.5 million).

Key Points: 
  • Ingevity Corporation (NYSE: NGVT) has completed its acquisition of the Capa caprolactone division of Perstorp Holding AB for a cash purchase price of 578.9 million ($652.5 million).
  • The acquisition is expected to be accretive to Ingevitys earnings and margins in the first year.
  • Capa is the global market leader in the production and commercialization of caprolactone and high-value downstream derivatives, including caprolactone polyols, caprolactone thermoplastics, caprolactone lactides, and hexanediol (HDO).
  • The Capa division is a strong, market-leading business focused on high-growth end-use applications and is an excellent fit with Ingevitys business model and capabilities, said Michael Wilson, Ingevity president and CEO.